---
title: 'Early Access to Testosterone Therapy in Transgender and Gender-Diverse Adults
  Seeking Masculinization: A Randomized Clinical Trial'
date: '2023-09-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37676662/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230907180928&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS AND RELEVANCE: In this open-label randomized clinical trial
  of testosterone therapy in transgender and gender-diverse adults, immediate testosterone
  compared with no treatment significantly reduced gender dysphoria, depression, and
  suicidality in transgender and gender-diverse individuals desiring testosterone
  ...'
disable_comments: true
---
CONCLUSIONS AND RELEVANCE: In this open-label randomized clinical trial of testosterone therapy in transgender and gender-diverse adults, immediate testosterone compared with no treatment significantly reduced gender dysphoria, depression, and suicidality in transgender and gender-diverse individuals desiring testosterone ...